Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases (VALIANT CAPTIVIA France)
Post-market Study on Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases
Sponsor: Medtronic Cardiovascular
This observational or N/A phase trial investigates Aorta Thoracic; Traumatic Rupture and Aortic Aneurysm, Thoracic and is currently completed. Medtronic Cardiovascular leads this study, which shows 12 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Feb 2021 — Mar 2022 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Nov 2019 — Feb 2020 [monthly]
Active Not Recruiting
-
Feb 2019 — Nov 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
First recorded
Mar 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiovascular
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Amiens, France , Bordeaux, France , Créteil, France , La Tronche, France , Le Chesnay, France , Le Plessis-Robinson, France , Limoges, France , Marseille, France , Paris, France , Saint-Martin-d'Hères, France and 3 more locations